Nortriptyline (Aventyl)
287
relevant articles (35 outcomes,
60 trials/studies)
found for this Drug
Description:
A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
Also Known As:
Aventyl; Pamelor; Nortriptyline Hydrochloride; Allegron; Apo-Nortriptyline; Apotex Brand of Nortriptyline Hydrochloride; Dista Brand of Nortriptyline Hydrochloride; Gen-Nortriptyline; Genpharm Brand of Nortriptyline Hydrochloride; Lilly Brand of Nortriptyline Hydrochloride; Lundbeck Brand of Nortriptyline Hydrochloride; Mallinckrodt Brand of Nortriptyline Hydrochloride; Norfenazin; Nortrilen; Novo-Nortriptyline; Novopharm Brand of Nortriptyline Hydrochloride; Nu-Nortriptyline; Nu-Pharm Brand of Nortriptyline Hydrochloride; PMS-Nortriptyline; Paxtibi; Pharmascience Brand of Nortriptyline Hydrochloride; Ratiopharm Brand of Nortriptyline Hydrochloride; Reig Jofre Brand of Nortriptyline Hydrochloride; ratio-Nortriptyline; Apo Nortriptyline; Gen Nortriptyline; Hydrochloride, Nortriptyline; Novo Nortriptyline; Nu Nortriptyline; Nu Pharm Brand of Nortriptyline Hydrochloride; PMS Nortriptyline; ratio Nortriptyline; Desitriptyline; Desmethylamitriptylin; 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methyl-
Relationship Network
Drug Context: Research Results
Experts
| 1. | Yeragani, Vikram K:
2 articles
(09/2002 - 01/2002)
|
| 2. | Pesce, Vanessa:
2 articles
(09/2002 - 01/2002)
|
| 3. | Roose, Steven:
2 articles
(09/2002 - 01/2002)
|
| 4. | Joyce, P R:
2 articles
(01/2002 - 12/2000)
|
| 5. | Mulder, R T:
2 articles
(01/2002 - 12/2000)
|
| 6. | Vancraynest, David:
1 article
(06/2008)
|
| 7. | Gurne, Olivier:
1 article
(06/2008)
|
| 8. | Hantson, Philippe:
1 article
(06/2008)
|
| 9. | De Roock, Sophie:
1 article
(06/2008)
|
| 10. | Gerber, Bernard:
1 article
(06/2008)
|
Related Diseases
| 1. | Pain (Aches)
|
| 2. | Stroke (Strokes)
|
| 3. | Tinnitus
01/01/1993
- " Both active drug and placebo were given for 6 weeks following a dose adjustment phase; the median nightly dose of nortriptyline was 100 mg. The two primary outcome variables were global satisfaction questions: "Has the medication helped you in any way?" and "Has your tinnitus improved?" Sixty-seven percent of nortriptyline patients stated the drug had helped them, versus 40 percent of placebo patients (chi-square = 7.14, p = 0.008)" 01/01/1992
- " Preliminary analysis of global outcome on the first 52 patients reveals that those receiving nortriptyline were more likely to feel that their drug had been helpful (74% vs. 36%, p less than 0.01), but were equally likely to report that their tinnitus was improved (37% vs. 32%, NS)" 11/01/1989
- " To explore further this link between tinnitus and depression, and to investigate the efficacy of treating depression in the treatment of tinnitus, a single-blind, placebo-washout, nonrandomized pilot study of the tricyclic antidepressant nortriptyline (hydrochloride) was undertaken in disabled tinnitus patients who also met diagnostic criteria for major depression" 10/11/1993
- " OBJECTIVE: To determine whether the antidepressant, nortriptyline, is effective for treatment of depression, tinnitus-related disability, and tinnitus symptoms in patients with severe chronic tinnitus" 11/01/1989
- " Fourteen considered their tinnitus improved, and 12 chose to continue taking nortriptyline after the study"
Order ALL the reference details at left...
|
| 4. | Depressive Disorder (Melancholia)
|
| 5. | Diabetes Mellitus
|
|
Related Drugs and Biologics